FDA Offers Guidance On Safety Testing For Gene-Editing Tech
By Dan McKay · April 14, 2026, 6:11 PM EDT
The U.S. Food and Drug Administration on Tuesday issued draft guidance recommending steps drug companies should take to evaluate the safety of gene-editing technology as they seek federal approval for cutting-edge...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login